2-oxindole has been researched along with Osteosarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernard, D; Carry, JC; Deschamps, JR; Ferey, V; Li, X; Liu, L; Lu, J; McEachern, D; Ochsenbein, P; Sun, D; Sun, W; Wang, S; Yu, S; Zhao, Y | 1 |
Aguilar, A; Bernard, D; Deschamps, JR; Liu, L; Lu, J; McEachern, D; Sun, W; Wang, S | 1 |
2 other study(ies) available for 2-oxindole and Osteosarcoma
Article | Year |
---|---|
Diastereomeric spirooxindoles as highly potent and efficacious MDM2 inhibitors.
Topics: Animals; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Cyclization; Humans; Indoles; Mice, SCID; Models, Molecular; Osteosarcoma; Oxindoles; Proto-Oncogene Proteins c-mdm2; Spiro Compounds; Stereoisomerism | 2013 |
Design of chemically stable, potent, and efficacious MDM2 inhibitors that exploit the retro-mannich ring-opening-cyclization reaction mechanism in spiro-oxindoles.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Proliferation; Cyclization; Drug Design; Humans; Indoles; Mice; Mice, SCID; Models, Molecular; Molecular Structure; Osteosarcoma; Oxindoles; Proto-Oncogene Proteins c-mdm2; Spiro Compounds; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |